ENSIGN GROUP, INC (ENSG) Form 8-K — Oct 27, 2026
The Ensign Group (ENSG) reported Q3 2026 results on October 27, 2026, with consolidated revenue of $1.48 billion, up 14.5% year over year, and GAAP net income of $104.3 million, up 24.4%. GAAP diluted EPS was $1.76 (+23.9% YoY) and adjusted EPS was $2.03 (+23.8%). Occupancy rose to 84.1% at Same Facilities and 86.1% at Transitioning Facilities, with Medicare revenue up 11.1% at Same Facilities. Management raised 2026 annual EPS guidance to $7.94-$8.02 from the original $7.75-$7.85, and raised the lower end of revenue guidance to $5.89 billion.
Key figures
- Eps
- 1.76
- Eps Beat
- GAAP diluted EPS +23.9% vs prior year quarter
- Revenue
- 1484002000
- Guidance
- 2026 annual EPS raised to $7.94-$8.02 (from $7.75-$7.85); annual revenue guidance lower end raised to $5.89 billion, upper end maintained at $5.92 billion; guidance assumes ~59.5M diluted shares and 25.0% tax rate
- Net Income
- 104384000
- Total Assets
- 5998390000
- Cash Position
- 337592000
- Adjusted eps q3
- 2.03
- Operating states
- 18
- Adjusted ebitda q3
- 190705000
- Nine month revenue
- 4313679000
- New operations added
- 22 new operations in the quarter and since (3 real estate assets, 19 leased), plus 5 previously-leased real estate properties acquired
- Nine month net income
- 303974000
- Operations since 2024
- 122
- Adjusted net income q3
- 120456000
- Standard bearer ffo q3
- 27316000
- Line of credit capacity
- 731600000
- Same facility occupancy
- 84.1% (+1.6 pts)
- Owned real estate assets
- 189
- Standard bearer revenue q3
- 47704000
- Total healthcare operations
- 418
- Quarterly dividend per share
- 0.065
- Transitioning facility occupancy
- 86.1% (+3.9 pts)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.